Xencor
XNCR
$23.63
Share price
-1.25%
Change (1 day)
-10.56%
Change (1 year)
Categories
EPS for Xencor (XNCR)
EPS in 2023 (TTM): -$2.14
According to Xencor's latest financial reports the company's current EPS (TTM) is -$2.14. In 2022 the company made an earnings per share (EPS) of -$0.92 a decrease over its 2021 EPS that were of $1.42.
EPS history for Xencor from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.14 | 132.61% |
| 2022 | -$0.92 | -164.79% |
| 2021 | $1.42 | -217.36% |
| 2020 | -$1.21 | -346.94% |
| 2019 | $0.49 | -136.57% |
| 2018 | -$1.34 | 24.07% |
| 2017 | -$1.08 | -283.05% |
| 2016 | $0.59 | -225.53% |
| 2015 | -$0.47 | -10.12% |
| 2014 | -$0.52 | -109.91% |
| 2013 | $5.27 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -758.19% | 🇺🇸 USA |
 AbbVie ABBV | $3.68 | -271.99% | 🇺🇸 USA |
 Amgen AMGN | $14.15 | -761.21% | 🇺🇸 USA |
 Merck MRK | $1.82 | -185.13% | 🇺🇸 USA |
 Seagen
SGEN | -$4.01 | 87.38% | 🇺🇸 USA |
 MacroGenics MGNX | $0.13 | -106.07% | 🇺🇸 USA |